Investigators pooled data from 4 trials to evaluate risk for recurrence in patients with intermediate risk non-muscle-invasive bladder cancer.

The preferred management of patients with recurrent platinum-sensitive ovarian cancer (PSOC) is platinum-based doublet therapy with selective ...

Investigators examined the effect of postpartum status on the 21-gene Oncotype DX Recurrence Score in women with hormone ...

Ashwin Kishtagari, MBBS, is Assistant Professor of Medicine in the division of hematology and oncology at Vanderbilt ...

In this analysis, researchers aimed to characterize dynamics involved in initial editorial review, subsequent peer review, and acceptance at two elite science journals.

Investigators explored national and state-level trends in mesothelioma incidence, mortality, disability burden, and occupational-attributable risk, stratified by sex, over the past 30 years.

Investigators conducted a cross-sectional survey to identify factors associated with psychological hardship related to the ...

Researchers conducted a pan-cancer analysis to examine the sex-based differences in cancer stage at diagnosis for various cancer sites.

The anti–lymphocyte activation gene 3 (LAG-3) antibody relatlimab demonstrated acceptable safety with or without nivolumab, and also provided preliminary immunologic and clinical findings for patients ...

Investigators conducted a retrospective study of patients treated for early-stage breast cancer at Fred Hutch Cancer Center to identify clinicopathologic factors associated with SLN-positivity (SLN+), ...

FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.

Investigators saw strong correlation between TTF and PFS for patients with poor prognosis and good prognosis. Time to treatment failure (TTF) is associated with progression-free survival (PFS) across ...